Pyruvate kinase M isoform 2 (PKM2) is preferentially expressed in nearly all cancers. It primarily functions as the last enzyme in glycolysis, but has other reported non-canonical functions, including recruiting transcription factors to oncogenes, and phosphorylating proteins. We previously described antisense oligonucleotides that disrupt alternative splicing of PKM pre-mRNA (PKM-ASOs), resulting in a PKM2-to-PKM1 isoform switch in hepatocellular carcinoma (HCC), which reduces HCC growth in vitro and in vivo.
View Article and Find Full Text PDFSevere sepsis is cognate with life threatening multi-organ dysfunction. There is a disturbance in endocrine functions with alterations in several hormonal pathways. It has frequently been linked with dysfunction in the hypothalamic pituitary-adrenal axis (HPA).
View Article and Find Full Text PDFThe ZrO-embedded carboxy-functionalized -BN composite, combined with graphene oxide (GO), formed a novel BN-COOH@ZrO/GO composite. Structural characterization through IR, Raman spectroscopy, powder X-ray diffraction, and X-ray photoelectron spectroscopy supported the successful preparation of the composite, while scanning electron microscopy and transmission electron microscopy revealed its surface morphology and the presence of component materials. UV-vis spectroscopy (solid state) further supported these findings.
View Article and Find Full Text PDFAdvanced Glycation End (AGE) products are one such factor that accumulates during aging and age-related diseases. However, how exogenous AGE compounds cause aging is an area that needs to be explored. Specifically, how an organ undergoes aging and aging-related phenomena that need further investigation.
View Article and Find Full Text PDFJ Cardiothorac Surg
December 2024
Tetralogy of Fallot (TOF) is the most common congenital cyanotic heart disease and is characterized by an antero-superior deviation of the infundibular septum with a consequent large malaligned ventricular septal defect (VSD) and a pulmonary and sub-pulmonary (infundibular) stenosis. Surgical repair has been the cornerstone of treatment that is electively performed early in their lives between 3 and 6 months of age. With advancements in transcatheter interventions, the complete percutaneous repair of TOF, a complex disease with multiple treatable lesions, is becoming a conceivable possibility.
View Article and Find Full Text PDF